GlaxoSmithKline Plc finished 2014 with turnover and operating profit broadly lower compared with a year earlier on the back of a drop in respiratory medicine sales in the US. Global vaccine and consumer healthcare sales also declined. ---Subscribe to MedNous to access this article--- Company News
